The Full Spectrum of News.
Published Watertown, United StatesUpdated

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - EyePoint Pharmaceuticals (NASDAQ:EYPT)

Summary by Benzinga
WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The …

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Wednesday, April 16, 2025.
Sources are mostly out of United States (1)

Subscribe to See The Whole Story

Get unlimited access to Ground News stories, the blindspot Feed, view ownership, bias and factuality ratings for thousands of sources, and compare headlines across the political spectrum.